Community Health Systems, Inc. (NYSE:CYH) Receives $2.95 Average PT from Brokerages

Shares of Community Health Systems, Inc. (NYSE:CYH) have been given a consensus rating of “Reduce” by the seven brokerages that are covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a sell rating, three have given a hold rating and one has assigned a buy rating to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $2.95.

A number of brokerages recently commented on CYH. Royal Bank Of Canada decreased their target price on Community Health Systems from $5.00 to $4.00 and set an “outperform” rating on the stock in a report on Monday, July 27th. Truist Financial reduced their price target on Community Health Systems from $3.75 to $3.25 and set a “hold” rating for the company in a research report on Monday, July 27th. Barclays decreased their price objective on Community Health Systems from $3.00 to $2.50 and set an “underweight” rating on the stock in a research note on Thursday, July 23rd. Weiss Ratings upgraded Community Health Systems from a “sell (d)” rating to a “sell (d+)” rating in a research note on Thursday, July 2nd. Finally, Wall Street Zen lowered shares of Community Health Systems from a “hold” rating to a “sell” rating in a report on Saturday, July 25th.

Community Health Systems Trading Up 0.5%

Shares of CYH stock opened at $2.79 on Wednesday. Community Health Systems has a 12 month low of $2.38 and a 12 month high of $4.43. The stock has a market cap of $392.71 million, a P/E ratio of 1.51 and a beta of 1.81. The company has a 50 day simple moving average of $3.11 and a two-hundred day simple moving average of $3.12.

Community Health Systems (NYSE:CYH) last issued its quarterly earnings results on Wednesday, July 22nd. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.09). Community Health Systems had a negative return on equity of 6.66% and a net margin of 2.10%.The business had revenue of $2.83 billion for the quarter, compared to analysts’ expectations of $2.89 billion. During the same quarter in the prior year, the business earned ($0.05) EPS. The company’s revenue was down 9.8% compared to the same quarter last year. Community Health Systems has set its FY 2026 guidance at -1.250–1.100 EPS. As a group, equities analysts forecast that Community Health Systems will post -0.69 earnings per share for the current year.

Institutional Trading of Community Health Systems

Several institutional investors and hedge funds have recently modified their holdings of the company. Royal Bank of Canada lifted its stake in shares of Community Health Systems by 601.9% during the 4th quarter. Royal Bank of Canada now owns 9,286 shares of the company’s stock valued at $29,000 after buying an additional 7,963 shares in the last quarter. Lazard Asset Management LLC purchased a new stake in Community Health Systems in the 4th quarter worth $34,000. Wealthcare Advisory Partners LLC bought a new stake in Community Health Systems during the fourth quarter valued at about $35,000. Valeo Financial Advisors LLC purchased a new position in shares of Community Health Systems in the fourth quarter valued at about $39,000. Finally, Quarry LP bought a new position in shares of Community Health Systems in the third quarter worth about $39,000. 84.99% of the stock is currently owned by institutional investors.

About Community Health Systems

Community Health Systems, Inc (NYSE: CYH) is one of the largest publicly traded hospital operators in the United States. Headquartered in Franklin, Tennessee, the company owns, leases and manages general acute care hospitals and outpatient facilities, primarily in non-urban and mid-market communities. CHS is focused on delivering locally accessible healthcare services through its network of affiliated hospitals, clinics and post-acute providers.

The company’s core offerings include inpatient medical and surgical care, emergency services, critical care, diagnostic imaging and laboratory testing.